Literature DB >> 10768078

Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations.

R A Balk1.   

Abstract

Severe sepsis and septic shock are frequently encountered conditions in today's hospital environment. The incidence appears to be increasing despite our growing armamentarium of antibiotics and our enhanced knowledge of the pathophysiologic processes at play. The clinical presentation may take a variety of forms, especially in patients at the extremes of age and in the immunocompromised population. A high index of suspicion and prompt institution of appropriate antimicrobial treatment is mandatory for a successful outcome. It is hoped that adoption of uniform definitions will aid in research and in effective communication concerning sepsis and its adverse sequelae.

Entities:  

Mesh:

Year:  2000        PMID: 10768078     DOI: 10.1016/s0749-0704(05)70106-8

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  68 in total

Review 1.  The cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: do they regulate each other?

Authors:  Dalia H A Abdelaziz; Hany Khalil; Estelle Cormet-Boyaka; Amal O Amer
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

2.  Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis.

Authors:  Ruonan Xu; Fang Lin; Chunmei Bao; Huihuang Huang; Chengcheng Ji; Siyu Wang; Lei Jin; Lijian Sun; Ke Li; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2015-03-02       Impact factor: 11.530

3.  Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.

Authors:  Vesna Degoricija; Mirella Sharma; Ante Legac; Marina Gradiser; Sinisa Sefer; Zeljko Vucicević
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

Review 4.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

5.  Antimicrobial susceptibility testing of Gram-positive and -negative bacterial isolates directly from spiked blood culture media with Raman spectroscopy.

Authors:  H E Dekter; C C Orelio; M C Morsink; S Tektas; B Vis; R Te Witt; W B van Leeuwen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-08       Impact factor: 3.267

6.  Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles.

Authors:  Erin J Kaleta; Andrew E Clark; Desiree R Johnson; Dulini C Gamage; Vicki H Wysocki; Abdessalam Cherkaoui; Jacques Schrenzel; Donna M Wolk
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

7.  Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells.

Authors:  Wei-Ching Huang; Yee-Shin Lin; Chi-Yun Wang; Cheng-Chieh Tsai; Hsiang-Chi Tseng; Chia-Ling Chen; Pei-Jung Lu; Po-See Chen; Li Qian; Jau-Shyong Hong; Chiou-Feng Lin
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

8.  Different mechanism of LPS-induced vasodilation in resistance and conductance arteries from SHR and normotensive rats.

Authors:  Nelson C Farias; Gisele L Borelli-Montigny; Grasiele Fauaz; Teresa Feres; Antonio C R Borges; Therezinha B Paiva
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 9.  Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Authors:  Hilmar Burchardi; Heinz Schneider
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults.

Authors:  Kevin B Laupland
Journal:  Can J Infect Dis       Date:  2002-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.